Dr. George W Walters, Jr, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 725 W Market St, Bolivar, TN 38008 Phone: 731-658-5197 Fax: 731-658-5245 |
Vision Center Optometrist Medicare: Not Enrolled in Medicare Practice Location: 725 W Market St, Bolivar, TN 38008 Phone: 731-658-5197 Fax: 731-658-5245 |
Dr. Elizabeth Gault Ligon, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 725 W Market St, Bolivar, TN 38008 Phone: 731-658-5197 Fax: 731-658-5197 |
Hardeman County Vision Center Inc Optometrist Medicare: Medicare Enrolled Practice Location: 725 W Market St, Bolivar, TN 38008 Phone: 731-658-5197 Fax: 731-658-5245 |
News Archive
Sydney's Centenary Institute has developed a new therapeutic approach that could help to improve outcomes for patients undertaking treatment for blood cancer.
Advanced Life Sciences Holdings, Inc. (OTC Bulletin Board: ADLS) today announced that the United States Food and Drug Administration (FDA) has granted Orphan Drug Designation to Restanza(TM) (cethromycin), its novel, once daily oral antibiotic, for the prophylactic treatment of plague and tularemia. Both tularemia and plague are classified by the Centers for Disease Control as Category A Bioterrorism Agents, which is the highest priority classification.
Kornberg Associates | Architects has converted part of an existing building (Keen Hall), including a previously unused covered open area, into an innovative stem cell core facility for the University of California, Riverside. Ken Kornberg, president and founder, made the announcement.
An average of one in 100 children in the United States has an autism spectrum disorder according to the Centers for Disease Control and Prevention. While over the last few years an increasing number of these children have begun to receive early intervention services, research shows that high quality and intensive intervention are critical for positive outcomes.
Researchers at Queen's University Belfast have devised a 'magic bullet' nanomedicine which could become the first effective treatment for Acute Lung Injury or ALI, a condition affecting 20 per cent of all patients in intensive care.
› Verified 2 days ago